You are here


March 18, 2015
MHRP and Colleagues Featured in Special JAIDS Supplement

MHRP's Global Health Programs (GHP) collaborated on a special supplement to the latest edition of the Journal of Acquired Immune Deficiency Syndromes (JAIDS). This special issue features literature reviews that examines the impact of HIV care and treatment interventions in low- and middle-income countries. It was supported by U.S. President's Emergency Plan for AIDS Relief. GHP's Director Dr....

February 26, 2015
Bioethics Commission Urges US to Adopt Ethical Approach to Ebola & Health Preparedness

Today, the Presidential Commission for the Study of Bioethical Issues (Bioethics Commission) argued that the federal government has both a prudential and a moral responsibility to actively participate in coordinated global responses to public health emergencies wherever they arise.The report, "Ethics and Ebola: Public Health Planning and Reponse," details findings and recommendations from the...

February 20, 2015
Building on RV144: HIV Vaccine Trial Launches in South Africa

A clinical trial called HVTN 100 has been launched in South Africa to study an investigational HIV vaccine regimen for safety and the immune responses it generates in study participants. This experimental vaccine regimen is based on the one tested in the U.S. Military HIV Research Program-led RV144 clinical trial in Thailand—the first study to demonstrate that a vaccine can protect people from...

February 6, 2015
New Cohort Study Begins in Mozambique

MHRP recently began a new cohort study, RV363, to assess the incidence of HIV and the willingness of adults to participate in future HIV vaccine trials in Mozambique. The study will determine incidence in men and women aged 18–35 in both Maputo and Beira. 

The retention rate of the enrolled cohort will be assessed over a 2-year follow-up period with a quarterly follow-up visit. RV363...

January 29, 2015
At the Frontlines of an Epidemic: Combating Ebola in Liberia

Last fall, CDR Jennifer Malia, DrPH, MHRP’s Assistant Chief of the Department of Laboratory Diagnostics and Monitoring, jumped at the opportunity to deploy to Liberia and treat Ebola patients. Malia spent more than a month in Monrovia, setting up a dedicated Ebola Treatment Center for health care workers and running a laboratory.

When the Public Health Service’s Chief Medical Officer...

December 23, 2014
Study confirms Ebola and Marburg Virus DNA Vaccines are Safe and Immunogenic in Africa

Results from the first Ebola vaccine clinical trial conducted in Africa (in 2009-2010) reveal a vaccine candidate produces the same immune response seen in the United States in an African setting. Importantly, this vaccine candidate is a precursor to candidates currently under evaluation for potential testing in West Africa. The findings of this 2009-2010 study, published online today in The...

December 8, 2014
New Journal of Virus Eradication Launches Today

MHRP's Dr. Jintanat Anaworanich is the Editor in Chief of a new scientific journal that aims to advance research in viral remission. The Journal of Virus Eradication (JVE) encompasses all aspects of viral disease including basic, clinical, behavioral, social and ethical research.  

For the inaugural issue, Dr. Anaworanich co-authored an editorial on the current direction and future...

December 1, 2014
World AIDS Day: Accelerating the Hunt for An Effective HIV Vaccine

On World AIDS Day (Dec. 1), two leading HIV researchers are calling on the global community to renew the sense of urgency around developing a safe and effective vaccine against HIV/AIDS. In an editorial published in the scientific journal Cell, US Army Col. Nelson Michael at the Walter Reed Army Institute of Research (WRAIR) and Dan Barouch, a Harvard Medical School Professor at Beth Israel...

December 1, 2014
Dr. Jintanat Ananworanich Recieves Princess Soamsawali's Award in Thailand

On World AIDS Day, MHRP’s Dr.Jintanat Ananworanich was given an award from Her Royal Highness Princess Soamsawali for her major contributions to the advancement of HIV care and research in Thailand.

The “Thian Song Jai” (candle light in the mind) ceremony has been organized by the Thai Red Cross each year on World AIDS Day for the past 23 years to increase the public’s awareness of HIV/...

November 20, 2014
In Uganda, MHRP Researchers Find Viral Burden to be Primary Predictor of HIV Disease Progression

New findings published this week in the Journal of Infectious Diseases found HIV-1 viral load and subtype to be the primary predictors of disease progression in rural Uganda. 

The findings from the collaborative study, lead by researchers at the U.S. Military HIV Research Program (MHRP), is contrary to current understanding that T-cell activation predicts disease progression...